MEDIVATION INC (MDVN)
(Delayed Data from NSDQ)
$81.44 USD
+0.02 (0.03%)
Updated Sep 27, 2016 04:14 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$81.44 USD
+0.02 (0.03%)
Updated Sep 27, 2016 04:14 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
M&A Boosts Intersil, Syngenta and Medivation in Pre-Market
by Mark Vickery
We???re seeing big gains among smaller companies ready to be purchased by much bigger fish: PFE, MDVN, SYT, ISIL.
Stock Market News for July 07, 2016
by Zacks Equity Research
Benchmarks ended in the green on Wednesday after the FOMC minutes from June meeting showed that most of the Fed policymakers were in favor of keeping rates unchanged.
Vertex Pharmaceuticals Posts Narrower-than-Expected Loss
by Zacks Equity Research
Vertex Pharmaceuticals's (VRTX) third-quarter 2014 loss came in at 56 cents per share wider than the year-ago loss of 46 cents.